Doximity, Inc. (NASDAQ:DOCS) Given Consensus Rating of “Hold” by Analysts

Shares of Doximity, Inc. (NASDAQ:DOCS) have been assigned a consensus rating of “Hold” from the twenty brokerages that are presently covering the stock, Marketbeat Ratings reports. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $53.12.

Several equities research analysts recently commented on DOCS shares. Canaccord Genuity Group restated a “hold” rating and set a $60.00 price objective (up from $40.00) on shares of Doximity in a research report on Wednesday, November 13th. Bank of America upped their price target on shares of Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. KeyCorp lowered their price objective on Doximity from $70.00 to $65.00 and set an “overweight” rating on the stock in a report on Wednesday, January 8th. Raymond James reissued an “outperform” rating and set a $65.00 target price (up previously from $37.00) on shares of Doximity in a report on Friday, November 8th. Finally, Evercore ISI lifted their price target on Doximity from $34.00 to $45.00 and gave the stock an “in-line” rating in a research note on Tuesday, October 8th.

Institutional Trading of Doximity

Several institutional investors have recently made changes to their positions in the company. American Century Companies Inc. lifted its position in Doximity by 0.9% in the second quarter. American Century Companies Inc. now owns 209,772 shares of the company’s stock valued at $5,867,000 after buying an additional 1,786 shares during the last quarter. Envestnet Asset Management Inc. lifted its holdings in shares of Doximity by 16.5% in the 2nd quarter. Envestnet Asset Management Inc. now owns 148,584 shares of the company’s stock worth $4,156,000 after acquiring an additional 21,005 shares during the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Doximity by 28.5% during the 2nd quarter. Dimensional Fund Advisors LP now owns 1,267,067 shares of the company’s stock worth $35,439,000 after purchasing an additional 281,239 shares during the period. Vanguard Personalized Indexing Management LLC increased its holdings in Doximity by 34.5% in the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 12,510 shares of the company’s stock valued at $350,000 after purchasing an additional 3,209 shares during the last quarter. Finally, Blair William & Co. IL raised its position in Doximity by 10.5% in the second quarter. Blair William & Co. IL now owns 100,139 shares of the company’s stock valued at $2,801,000 after purchasing an additional 9,539 shares during the period. Hedge funds and other institutional investors own 87.19% of the company’s stock.

Doximity Stock Performance

Shares of DOCS opened at $55.38 on Tuesday. The business’s 50-day moving average is $53.86 and its two-hundred day moving average is $43.86. The company has a market capitalization of $10.34 billion, a P/E ratio of 63.66, a P/E/G ratio of 4.43 and a beta of 1.38. Doximity has a fifty-two week low of $22.96 and a fifty-two week high of $61.75.

Doximity (NASDAQ:DOCS) last posted its earnings results on Thursday, November 7th. The company reported $0.24 EPS for the quarter, missing the consensus estimate of $0.26 by ($0.02). Doximity had a return on equity of 19.79% and a net margin of 33.69%. The company had revenue of $136.83 million for the quarter, compared to analyst estimates of $127.05 million. During the same period last year, the business earned $0.18 earnings per share. Analysts forecast that Doximity will post 0.88 EPS for the current year.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.